Chondroitin sulfate in osteoarthritis therapy

Orthopedics

Volumn 32, Issue 4, 2009, Pages 268-

  Morris, Jonathan D ^a   Smith, Kelly M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; ANALGESIC AGENT; CHONDROITIN SULFATE; HYALURONIC ACID; IBUPROFEN; INDOMETACIN; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENZYME ACTIVITY; INCIDENCE; KNEE OSTEOARTHRITIS; NONHUMAN; OUTCOME ASSESSMENT; PREVALENCE; PROTEIN SYNTHESIS; RAT; SHORT SURVEY; TREATMENT OUTCOME; UNITED STATES; DOSE RESPONSE; HUMAN; REVIEW;

CHONDROITIN SULFATES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; TREATMENT OUTCOME;

EID: 67649103837     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20090401-04     Document Type: Short Survey

References (15)

1. Garstang SV, Stitik TP. Osteoarthritis: epidemiology, risk factors, and pathophysiology. Am J Phys Med Rehabil. 2006; 85(11 suppl):S2-S11.
2. Bruyere O, Reginster JY. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging. 2007; 24(7):573-580. (Pubitemid 47195676)
3. Krishnan SP, Skinner JA. (i) Novel treatments for early osteoarthritis of the knee. Curr Orthpaed. 2005; 19(6):407-414.
4. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New Engl J Med. 2006; 354(8):795-808. (Pubitemid 43290918)
5. Band P. Several meta-analyses have analyzed its safety and effectiveness - chondroitin sulfate for osteoarthritis: interpreting divergent evidence. J Muscoskel Pain. 2007; 24(4):422-428.
6. Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthr Cartilage. 1998; (6 suppl A):14-21.
7. Bourgeois P, Chales G, Dehais J, Delcambre B, Kuntz J, Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3x400 mg/day vs placebo. Osteoarthr Cartilage. 1998; (6 suppl A):25-30.
8. Michel BA, Stucki G, Frey D, et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum. 2005; 52(3):779-786. (Pubitemid 40365099)
9. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15(12):1833-1840. (Pubitemid 19037656)
10. Sawitzke AD, Shi H, Finco MF, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum. 2008; 58(10):3183-3191.
11. Hathcock JN, Shao A. Risk assessment for glucosamine and chondroitin sulfate. Regul Toxicol Pharmacol. 2007; 47(1):78-83. (Pubitemid 44765124)
12. Gregory PJ, Sperry M, Friedman AF. Dietary supplements for osteoarthritis. Am Fam Physician. 2008; 77(2):177-184.
13. American Academy of Orthopaedic Surgeons. Guideline on the treatment of osteoarthritis (OA) of the knee. http://www.aaos.org/Research/guidelines/ GuidelineOAKnee.asp. Accessed January 12, 2009.
14. Samson DJ, Grant MD, Ratko TA, Bonnell CJ, Ziegler KM, Aronson N. Treatment of primary and secondary osteoarthritis of the knee. Evid Rep Technol Assess (Full Rep). 2007; (157):1-157.
15. National Center for Complimentary and Alternative Medicine. The NIH glucosamine/chondroitin arthritis intervention trial (GAIT). J Pain Palliat Care Pharmacother. 2008; 22(1):39-43.